Evidence map›Paper›PMID 41276718›Full record

ArticleJournal of robotic surgery2025

Early catheter removal after Retzius-sparing robot-assisted radical prostatectomy.

Nicolaas Lumen, Zeyu Wang, Lies Van den Eynde, Antonio Franco, Beatrice Turchi, Camille Berquin, Charles Van Praet

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nicolaas Lumen *Department of Urology, Ghent University Hospital, C. Heymanslaan 10, Ghent, 9000, Belgium.
Zeyu Wang *Department of Urology, Ghent University Hospital, C. Heymanslaan 10, Ghent, 9000, Belgium. zeyu.wang@ugent.be.
Lies Van den EyndeDepartment of Urology, Ghent University Hospital, C. Heymanslaan 10, Ghent, 9000, Belgium.
Antonio FrancoDepartment of Urology, Ghent University Hospital, C. Heymanslaan 10, Ghent, 9000, Belgium.
Beatrice TurchiDepartment of Urology, Ghent University Hospital, C. Heymanslaan 10, Ghent, 9000, Belgium.
Camille BerquinDepartment of Urology, Ghent University Hospital, C. Heymanslaan 10, Ghent, 9000, Belgium.
Charles Van PraetDepartment of Urology, Ghent University Hospital, C. Heymanslaan 10, Ghent, 9000, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the feasibility of early catheter removal (< 3 days; ECR) after Retzius-sparing robot assisted radical prostatectomy (RS-RARP).

methodsPatients with non-metastatic prostate cancer without prior prostate surgery who underwent RS-RARP were assessed for reasons for the direct decision of delayed catheter removal (> 3 days; ddDCR). Furthermore, differences in patient characteristics and retention rate when the catheter was removed after 2 days (very ECR; VECR) or 3 days (standard ECR; SECR) were assessed and predictors of retention in the ECR were analyzed.

resultsOut of 343 patients, 31 patients (9%) needed ddDCR mainly due to anastomotic leakage or complex cases. Respectively 238 and 74 patients underwent SECR and VECR. Patients with VECR had significantly shorter operation time, more favorable risk group stratification, and more frequent bladder neck sparing compared to SECR. Patients after VECR had a significantly shorter hospital stay compared to SECR (2 versus 3 days; p < 0.001). The retention rate after VECR, SECR, and ddDCR was respectively 17.6%, 10.1%, and 3.2% (p = 0.084). There were no significant differences in patient-reported continence rates among groups. Retention could not predict continence. No predictor for retention could be identified.

conclusionsECR is possible in the large majority of patients undergoing RS-RARP. VECR is possible in selected patients and reduces hospital stay. However, the risk of retention after ECR should be informed. These results provide reliable evidences for perioperative management decisions in RS-RARP.

Indexed as

Device RemovalOrgan Sparing TreatmentsProstatectomyProstatic NeoplasmsRobotic Surgical ProceduresUrinary CatheterizationAgedFeasibility StudiesHumansLength of StayMaleMiddle AgedOperative TimeRetrospective StudiesTime FactorsComplicationProstate cancerRARPRobotic surgeryUrethral catheterUrinary retention

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.